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Abstract 
Background: The early prediction of the severity of acute pancreatitis still represents a challenge for clinicians. 
Experimental studies have revealed the generation of specific halogenated lipids, in particular oleic acid chlorohydrin, 
in the early stages of acute pancreatitis. We hypothesized that the levels of circulating oleic acid chlorohydrin might 
be a useful early prognostic biomarker in acute pancreatitis in humans.
Methods: In a prospective, multicenter cohort study, plasma samples collected within 24 h after presentation in the 
emergency room from 59 patients with acute pancreatitis and from 9 healthy subjects were assessed for oleic acid 
chlorohydrin levels.
Results: Pancreatitis was mild in 30 patients, moderately severe in 16 and severe in 13. Oleic acid chlorohydrin levels 
within 24 h after presentation were significantly higher in patients that later progressed to moderate and severe acute 
pancreatitis. Using 7.49 nM as the cutoff point, oleic acid chlorohydrin distinguished mild from moderately severe‑to‑
severe pancreatitis with high sensitivity/specificity (96.6/90.0%) and positive/negative predictive values (90.3/96.4%). 
Using 32.40 nM as the cutoff value sensitivity, specificity, positive and negative predictive values were all 100% for 
severe acute pancreatitis. It was found to be a better prognostic marker than BISAP score, hematocrit at 48 h, SIRS at 
admission, persistent SIRS or C‑reactive protein at 48 h.
Conclusions: Oleic acid chlorohydrin concentration in plasma is elevated in patients with acute pancreatitis on 
admission and correlates with a high degree with the final severity of the disease, indicating that it has potential to 
serve as an early prognostic marker for acute pancreatitis severity.
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Background
Acute pancreatitis (AP) is an abrupt inflammatory pro-
cess of the pancreas that often involves peripancreatic 
tissues and distant organs [1] and is one of the most com-
mon causes of hospital admission due to gastrointestinal 
disease [2]. The severity of the disease is highly variable, 
ranging from a mild and self-limited form to a severe 
disease with local and systemic complications that may 
lead to multiorgan failure and death [3].
The early prediction of severity becomes a critical issue 
in the management of AP. When the prediction is accu-
rate, it allows for proper patient stratification with clini-
cal management implications: Patients predicted at risk 
of developing severe AP will get enhanced hemodynamic 
support and close monitoring aimed at prompt recogni-
tion of local or systemic complications that may require 
specific treatment. Unfortunately, our ability to identify 
with high accuracy those severe cases early in the course 
of the disease is still unsatisfactory. The current predic-
tion of severity is mainly based on multifactorial scores 
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(Ranson, Imrie, APACHE-II, BISAP, etc.) [4, 5]. However, 
some of them are cumbersome to calculate (APACHE-
II, Ranson, Imrie) and, most importantly, these scoring 
systems have a limited accuracy for mortality or per-
sistent organ failure (>  48  h) [5–8]. In addition, some 
reports indicate that these scoring systems are not supe-
rior to easier-to-determine biomarkers, such as blood 
urea nitrogen, C-reactive protein (CRP), hematocrit or 
creatinine [6]. In this scenario, a blood biomarker with 
improved accuracy in predicting severe AP (as compared 
to previously described predictors) would be a step for-
ward toward better early management of patients with 
severe AP.
In previous studies using an experimental model of tau-
rocholate-induced acute pancreatitis in rats, we observed 
the generation and release to the bloodstream of specific 
halogenated lipids [9]. The infiltration and activation of 
polymorphonuclear neutrophils in the pancreas, but 
also in surrounding areas of adipose tissue, result in the 
generation of hypochlorous acid (HOCl) from hydrogen 
peroxide  (H2O2) and chloride ions, in a reaction cata-
lyzed by myeloperoxidase (MPO) [10]. The combination 
of high MPO and pancreatic lipase activity results in the 
generation and release of fatty acid chlorohydrins (Fig. 1), 
being the oleic acid chlorohydrin (OAC) the most abun-
dant of them.
It is important to note that the generation of these hal-
ogenated fatty acids requires a combination of processes 
that are triggered during the development of pancreatitis, 
particularly when the enhanced inflammatory response 
acquires such characteristics that herald the progres-
sion to severe AP. This inflammatory response involves 
the recruitment of macrophages and neutrophils to the 
damaged pancreas and to the surrounding adipose tis-
sue. These cells release active MPO in the areas where 
large amounts of pancreatic lipase catalyze the hydroly-
sis of triacylglycerols from adipocytes [11]. Therefore, 
fatty acid chlorohydrins (and in particular OAC) genera-
tion is fostered by the combined action of two enzymatic 
systems (myeloperoxidase and lipase) that are overactive 
in severe AP. Furthermore, OAC can be released to the 
bloodstream and its blood levels quantitated.
Experimental studies pointed to an interesting cor-
relation between the levels of circulating OAC and the 
severity of acute pancreatitis [12]. However, the potential 
use of plasma OAC concentration as an early biomarker 
Fig. 1 Generation of oleic acid chlorohydrin in acute pancreatitis. TAG triacylglycerol; MPO myeloperoxidase
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for severe AP in humans has not been evaluated yet. In 
this study, we assessed the effectiveness and feasibility of 
OAC in the early prediction of severity of acute pancrea-
titis in humans.
Methods
The relationship between OAC plasma levels and out-
come of AP was studied in a prospective cohort of con-
secutive patients from two medical centers: Hospital 
General Universitario de Alicante (Alicante, Spain) and 
Hospital Universitari Vall d’Hebron (Barcelona, Spain). 
The study protocol was approved by the ethic committee 
of both centers and followed the Declaration of Helsinki 
Ethical Principles for Medical Research Involving Human 
Subjects. The patients signed an informed consent before 
entering the study.
Study population
Adult (≥  18  years) patients with AP were prospectively 
recruited for 6 months. AP was defined according to the 
revised Atlanta classification. At least two of the follow-
ing three features should be presented: (1) abdominal 
pain consistent with acute pancreatitis (acute onset of a 
persistent, severe, epigastric pain often radiating to the 
back); (2) serum lipase activity (or amylase activity) at 
least three times greater than the upper limit of normal; 
and (3) characteristic findings of acute pancreatitis on 
contrast-enhanced computed tomography (CECT) and 
less commonly on magnetic resonance imaging (MRI) or 
on transabdominal ultrasonography [13]. We excluded 
patients with recurrent acute pancreatitis, chronic pan-
creatitis, pancreatitis due to malignancy, pregnant 
patients, patients with time from onset of disease to pres-
entation in the emergency room greater than 24  h and 
patients being hospitalized for more than 24 h at the time 
of recruitment.
Variables
Local and systemic complications were defined accord-
ing to the revised Atlanta classification [13], and systemic 
inflammatory response syndrome (SIRS) was defined 
according to usual criteria [14]. We compared the prog-
nostic accuracy of OAC with other commonly used prog-
nostic markers and scores: BISAP score [15], C-reactive 
protein at 48 h from presentation [16], presence of SIRS 
criteria at emergency room and presence of persistent 
SIRS (> 48 h) [17, 18] and hematocrit at emergency room 
higher than 44% [19]. Charlson comorbidity index was 
used to describe comorbidity [20].
Outcome variables were defined according to the 
revised Atlanta classification [13]: moderately severe-
to-severe disease (presence of local or systemic 
complications in general), severe disease (presence of 
persistent organ failure) and in-hospital mortality.
Blood samples
Blood samples were collected from each patient within 
24  h after presentation in the emergency room, drawn 
into 5-ml heparin-treated tubes and centrifuged for 
10 min at 1500×g. The plasma was then collected and 
stored at −  40  °C until analysis. Healthy controls were 
recruited from hospital staff. Assessment of OAC con-
centration was done blindly.
Oleic acid chlorohydrin analysis by mass spectrometry
Samples were fortified with 18,18,18-d3-octadecanoic 
acid (20 nmol) and extracted with hexane (four volumes). 
The organic extract was evaporated and lipid extracts 
were derivatized with bis-trimethylsilyltrifluoroaceta-
mide and injected the GC–MS system [21]. Endogenous 
levels of fatty acid chlorohydrins were thus quantified by 
selected ion monitoring (SIM).
Gas chromatography coupled to electron impact 
(70 eV) mass spectrometry was carried out as described 
[21] with minor modifications. Selected ions were those 
at m/z 344 and m/z 359 ([(M-CH3)+ and (M)+, trimethyl-
silyl (TMS) derivative of internal standard]; m/z 215 
(TMS derivative of oleic acid chlorohydrin) and m/z 317 
(common to the TMS derivatives of both the chlorohy-
drins of oleic and linoleic acids).
Statistical methods
Results are expressed in mean (SD), median (Q1, Q3) 
or n (%). Normality was assessed by means of the Sha-
piro–Wilk test. Quantitative variables were compared 
with qualitative variables by means of the Student t/
Mann–Whitney tests (2 categories) or ANOVA/Kruskal–
Wallis tests (>  2 categories). Qualitative variables were 
compared by means of the Chi-square test, with Fisher’s 
correction when necessary. Receiver operating charac-
teristics (ROC) curves were calculated for assessing the 
prognostic accuracy and for determining the best cutoff 
points. Sensitivity (Se), specificity (Sp) and positive/nega-
tive predictive values (PPV and NPV, respectively) were 
calculated. A P value less than 0.05 indicated statistical 
significance, but we applied the Bonferroni correction 
when multiple comparisons were performed. Statisti-
cal analyses were performed using SPSS 19.0 (SPSS, Inc., 
Chicago, Illinois, USA).
Results
Demographic, clinical and biochemical characteristics 
of patients
Fifty-nine patients and nine healthy subjects entered the 
study. Based on the revised Atlanta classification [13], 30 
Page 4 of 8de‑Madaria et al. Ann. Intensive Care  (2018) 8:1 
patients had mild AP, 16 developed moderately severe 
AP and 13 severe AP. As the two hospitals are transfe-
ral centers where they derived the most serious cases, 
the percentage of severe pancreatitis is relatively high. 
Patient’s basal clinical characteristics as well as outcomes 
according to severity are shown in Table  1. Gallstones 
were the main etiological factor, followed by alcohol 
abuse and endoscopic retrograde cholangiopancreatog-
raphy (ERCP). Eight patients with severe AP died (5 of 
them with infected pancreatic necrosis). No significant 
differences were observed in age, gender or BMI  >  30 
between groups.
Oleic acid chlorohydrin levels in plasma
Median OAC plasma concentration raised as the severity 
of AP increased. Significant differences in plasma OAC 
levels were detected among the different group catego-
ries of AP studied: mild, moderately severe and severe 
(Fig.  2), with lower levels in the mild acute pancreatitis 
group (median 2.6 nM; 1.3–5) as compared with moder-
ate (14.7  nM; 9.1–22.65) and severe (65.2  nM; 42–71.4) 
groups. OAC was significantly different in all the possible 
comparisons between controls, mild, moderately severe 
and severe categories (Fig.  2). In control samples, OAC 
was only detected in a few samples (0.0 nM; 0–3.1).
Prognostic accuracy of OAC and other predictors
Regarding the prediction of moderately severe-to-severe 
AP, the ROC curves for OAC, BISAP score and CRP 
are shown in Fig. 3. OAC levels had a higher ROC AUC 
Table 1 Demographic characteristics and outcomes of the study patients according to severity
Results in median (p25, p75) or n (%)
BISAP Bedside index of severity in acute pancreatitis, SIRS systemic inflammatory response syndrome, OAC oleic acid chlorohydrin, CRP C‑reactive protein, ERCP 
endoscopic retrograde cholangiopancreatography, ER emergency room. Please note that persistent organ failure defines the severe category on the revised Atlanta 
classification
P statistical significance for the comparison between the mild, moderately severe and severe categories
Global sample (n = 59) Mild (n = 30) Moderately severe (n = 16) Severe (n = 13) P
Age (years) 64 (50.5–77) 62.5 (49.5, 72.3) 66.5 (53.5, 77.8) 77 (42, 81.5) 0.5
Female sex 33 (55.9%) 19 (63.3%) 9 (56.3%) 5 (38.5%) 0.3
Etiology 0.065
 Biliary 24 (40.7%) 13 (43.3%) 7 (43.8%) 4 (30.8%)
 Alcohol 8 (13.6%) 1 (3.3%) 4 (25%) 3 (23.1%)
 Post‑ERCP 7 (11.9%) 3 (10%) 2 (12.5%) 2 (15.4%)
BMI > 30 kg/m2 14 (23.7%) 7 (23.3%) 3 (18.8%) 4 (30.8%) 0.749
BISAP score 1 (1, 2) 1 (0, 1.3) 2 (1, 3) 2 (1, 3) 0.005
Charlson index 0 (0, 1) 0 (0, 1) 1 (0, 2) 1 (2.5) 0.035
CRP at 48 h (mg/dL) 10.9 (3–24.2) 4.3 (1.8, 12.7) 19.8 (9.6, 28.4) 30.4 (23.2, 39.3) <0.001
OAC (nM) 7 (2.3–22.6) 2.6 (1.3, 5) 14.7 (9.1, 22.6) 65.2 (42, 71.4) <0.001
SIRS at ER 29 (49.2%) 9 (30%) 11 (68.8%) 9 (75%) 0.007
SIRS > 48 h 14 (23.7%) 0 3 (18.8%) 11 (84.6%) <0.001
Pancreatic necrosis 9 (15.3%) 0 3 (18.8%) 6 (46.2%) 0.001
Peripancreatic necrosis 15 (25.4%) 0 9 (56.3%) 6 (46.2%) <0.001
Infected necrosis 5 (8.5%) 0 0 5 (38.5%) <0.001
Persistent organ failure 13 (22%) 0 0 13 (100%) <0.001
Hospital stay (days) 12 (7–18.5) 8.5 (6, 12.3) 14 (11, 20) 32.5 (3.8, 52.3) 0.014
Mortality 0 0 8 (61.5%) <0.001
Fig. 2 Oleic acid chlorohydrin levels (nM) measured on admission 
in plasma of patients with acute pancreatitis that finally evolved into 
different disease severities. OAC oleic acid chlorohydrin; *P < 0.05; 
***P < 0.001. Level of significance according to Bonferroni correction: 
0.0125
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than BISAP score and CRP (Table 2). Using 7.49 nM as 
the cutoff point, OAC plasma concentration at admis-
sion could readily predict moderately severe or severe 
AP with a sensitivity of 96.6%, specificity of 90.0%, posi-
tive predictive value (PPV) of 90.3% and negative predic-
tive value (NPV) of 96.4%. Sensitivity and NPV for OAC 
were higher than for other commonly used predictors 
(Table 3).
OAC was an excellent predictor of severe disease (and 
persistent organ failure), again associated with higher 
AUC (1) than BISAP score and CRP (Table  2; Fig.  3). 
Using 32.40  nM as the cutoff value, OAC predicted 
severe disease with 100% sensitivity, specificity, PPV and 
NPV. This accuracy was higher than any other predictor 
evaluated in this study (Table 4).
It is interesting to note that all of the above results 
did not change significantly when data from patients 
recruited at each participating hospital were processed 
independently, indicating that the test performed equally 
well at the two hospitals.
Discussion
Early identification of severe forms of AP is essential for 
successful management of affected patients. Unfortu-
nately, early reliable and sensitive predictive markers of 
severity are not at hand for application in clinical prac-
tice beyond popular multifactorial scores [22–24]. Mod-
erately severe-to severe acute pancreatitis is believed 
to be the result of a multifactorial process that involves 
tissue necrosis, hydrolytic enzyme activation, release of 
inflammatory cytokines, generation of reactive oxygen 
species and synthesis of bioactive lipid mediators. In 
addition, some of these events take place in extra-pan-
creatic organs and none of them, by its own, is directly 
linked to the severity of the disease. Of note, pancreas-
derived mediators that proved valuable for severity pre-
diction in experimental animals have failed to predict 
the future course of pancreatitis when applied to human 
disease. The concomitant activation of different local and 
systemic processes explains the need for multifactorial 
scoring systems developed to predict the severity of AP, 
including Ranson criteria, APACHE-II or BISAP [5].
Fatty acid chlorohydrins are halogenated lipids gener-
ated by the action of hypochlorous acid on unsaturated 
Fig. 3 ROC curves of oleic acid chlorohydrin (OAC), C‑reactive protein (CRP) and BISAP score for the prediction of acute pancreatitis severity. a ROC 
curve for the prediction of moderately severe‑to‑severe disease. b ROC curve for the prediction of severe disease. OAC oleic acid chlorohydrin. CRP 
at 48 h C‑reactive protein at 48 h from admission. BISAP bedside index of severity in acute pancreatitis
Table 2 Area under the receiver operating characteristics 
curve for the prediction of moderately severe-to-severe 
disease, severe disease (persistent organ failure) and mor-
tality for oleic acid chlorohydrin, BISAP score and C-reac-
tive protein
AUC Area under the receiver operating characteristics curve, CI confidence 
intervals, OAC oleic acid chlorohydrin, BISAP Bedside index of severity in acute 
pancreatitis, CRP 48 h C‑reactive protein at 48 h from admission
Outcome to predict Predictor AUC (95% CI)
Moderately severe‑to‑severe disease OAC 0.954 (0.886–1)
BISAP score 0.732 (0.601–0.863)
CRP 48 h 0.837 (0.734–0.941)
Severe disease (persistent organ 
failure)
OAC 1
BISAP score 0.709 (0.547–0.871)
CRP 48 h 0.860 (0.720–1)
Mortality OAC 0.931 (0.866–0.997)
BISAP score 0.808 (0.668–0.948)
CRP 48 h 0.772 (0.529–1)
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fatty acids [10]. Although absent in control conditions, 
they can be released to the bloodstream during AP due 
to the combined effect of high lipase and MPO activities. 
Since this combination is characteristic of severe pan-
creatic/peripancreatic damage and enhanced systemic 
response, the presence of fatty acid chlorohydrins could 
only be expected to occur under the simultaneous acti-
vation of both hydrolytic and inflammatory processes 
that, when combined, are associated with the progression 
from mild to severe AP. Importantly, a number of pro-
inflammatory activities have also been reported for fatty 
acid chlorohydrins, including the induction of P-selectin 
and the activation of macrophages [9, 25].
The value of lipid metabolites as indicators of increased 
severity of AP has been progressively recognized. There 
are also some clues that point to an active role of lipid 
mediators in the progression of mild to severe AP, in 
particular on the systemic effects that may lead to organ 
failure. Obesity or increased intra-abdominal fat is asso-
ciated with severe AP, possibly through a mechanism 
related to the lipotoxic action of unsaturated fatty acids 
released by the effect of lipase on triglycerides of vis-
ceral adipocytes. In a series of elegant experiments, 
Navina et  al. [26] demonstrated the pathogenic role of 
unsaturated fatty acids released during pancreatitis on 
inflammation, necrosis, multisystem organ failure and 
mortality. The measurement of chlorohydrins of fatty 
acids is a further step on this direction since the pres-
ence of these molecules indicates that, in addition to 
the effects of hydrolytic enzymes released by the pan-
creas, the inflammatory microenvironment required 
for the halogenation of fatty acids becomes relevant in 
distant organs. Even when these reactions are only rel-
evant in local scenarios, the plasma levels of OAC are 
ultimately related to increased severity of AP and to mul-
tiorgan failure. The experimental study in rats indicates 
that release of OAC depends on the action of lipase fol-
lowing a kinetic similar to that observed for oleic acid, 
whereas its final course seems to be related to the hepatic 
uptake of free fatty acids [9]. Chlorinated fatty acids have 
been reported to be catabolized by hepatocytes through 
ω-oxidation and subsequent β-oxidation and their final 
products are rapidly excreted in urine [27]. Altogether it 
suggests that OAC could be a useful prognostic param-
eter but only in the initial stages of acute pancreatitis.
Our results in human patients confirm the expectations 
generated in experimental studies and show the value of 
OAC in predicting the course and outcome of AP. OAC 
was particularly accurate in predicting persistent organ 
failure and mortality, the most important outcome vari-
ables in AP. Our data reveal that levels of OAC meas-
ured on admission allow for discriminating the different 
degrees of severity to be developed on the progression of 
the disease in the long run, which should have a direct 
impact on the clinical management of these patients. 
According to our data, OAC concentrations higher than 
32.4  nM are associated with severe AP, while a cutoff 
value of 7.5 distinguishes mild from moderate and severe 
disease.
Like many other studies focusing on research of prog-
nostic biochemical markers, our study also has a number 
of methodological and technical limitations. The study 
includes patients from two hospitals, but, as expected, 
the number of patients in moderate and severe groups 
was significantly lower than in mild group. Therefore, out 
of 59 patients with AP only 13 had severe pancreatitis 
and 16 moderately severe. Although the results obtained 
allow to discriminate between these three groups with a 
good statistical level, there is no doubt that more studies 
Table 3 Prognostic accuracy of OAC for moderately 
severe-to-severe disease compared to other widely used 
predictors
Se Sensitivity, SP specificity, PPV/NPV positive/negative predictive values, POF 
persistent organ failure, OAC oleic acid chlorohydrin, SIRS systemic inflammatory 
response syndrome, HTC hematocrit, BISAP bedside index of severity in acute 
pancreatitis, CRP C‑reactive protein
Variable Se Sp PPV NPV
OAC ≥ 7.49 nM 96.6 90 90.3 96.4
SIRS at ER 71.4 70 69 72.4
Persistent SIRS 48.3 100 100 65.9
HTC at ER > 44% 44.8 66.7 56.5 55.6
BISAP ≥ 3 34.5 100 100 61.2
CRP ≥ 15 mg/dL at 48 h 68 80 73.9 75
Table 4 Prognostic accuracy of OAC for severe disease 
(persistent organ failure) and mortality compared to other 
widely used predictors
Se Sensitivity, SP specificity, PPV/NPV positive/negative predictive values, POF 
persistent organ failure, OAC oleic acid chlorohydrin, SIRS systemic inflammatory 
response syndrome, HTC hematocrit, BISAP bedside index of severity in acute 
pancreatitis, CRP C‑reactive protein
Variable Outcome to predict Se Sp PPV NPV
OAC ≥ 32.4 nM Severe disease 100 100 100 100
Mortality 100 90.2 61.5 100
SIRS at ER Severe disease 75 56.5 31 89.7
Mortality 85.7 54.9 20.7 96.6
Persistent SIRS Severe disease 84.6 93.3 78.6 95.5
Mortality 75 84 42.9 95.5
HTC at ER > 44% Severe disease 38.5 60.9 21.7 77.8
Mortality 25 58.8 8.7 83.3
BISAP ≥ 3 Severe disease 38.5 89.1 50 83.7
Mortality 50 88.2 40 91.8
CRP ≥ 15 mg/dL at 48 h Severe disease 90 68.9 39.1 96.9
Mortality 80 62 17.4 96.9
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with a much higher number of patients need to be done. 
Anyway, OAC was very accurate to detect severity and 
was compared with preexisting predictors of severity that 
were applied to the same sample showing a lower accu-
racy. On the other hand, the generation of OAC through 
the incorporation of the HOCl to the 9,10 double bond of 
oleic acid results in the formation of two isomeric chlo-
rohydrins (the 9-chloro, 10-OTMS 18:0 chlorohydrin 
and the 9-OTMS, 10-chloro 18:0 chlorohydrin). These 
compounds are not separated by the GC column and, 
although this limitation may have little impact on the 
overall results of our study, we have to acknowledge that 
our data indicate the sum of the two isomers. In addition, 
it must be taken into account that, although the meas-
ure of OAC by gas chromatography/mass spectrometry 
is too complex and slow to be applied to clinical prac-
tice, ELISA tests similar to those for prostaglandins and 
other lipid metabolites can be easily developed allowing 
for much faster measurements of OAC. Availability of 
faster and easier assays methods will make easier to con-
firm our results in larger samples of patients. In this line, 
although these encouraging results have been obtained 
from two independent cohorts of patients from two dif-
ferent and geographically remote hospital centers, they 
should be validated in larger cohort studies performed by 
other groups. In case of similar results, OAC would be, 
by far, the most accurate early predictor of severe acute 
pancreatitis ever described.
Conclusions
In summary, this study demonstrates that OAC is gen-
erated during AP, it can be measured in plasma, and its 
levels correlate with pancreatitis severity. Our findings 
indicate that oleic acid chlorohydrin is an accurate early 
prognostic biomarker to be used in patients with acute 
pancreatitis.
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